REQUEST A DEMO
Total
USD $0.00
Search more companies

Renofarma Tovacov, S.R.O. (Czech Republic)

Main Activities: All Other Miscellaneous Crop Farming
Full name: Renofarma Tovacov, S.R.O. Profile Updated: November 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Renofarma Tovacov, S.R.O. is a company in Czech Republic, with a head office in Tovacov. The company operates in the All Other Miscellaneous Crop Farming sector. The enterprise was incorporated on October 14, 1993. It currently has a total number of 25 - 49 (2024) employees. From the latest financial highlights, Renofarma Tovacov, S.R.O. reported a net sales revenue increase of 39.71% in 2022. Its’ total assets recorded a growth of 24.3%. In 2022, Renofarma Tovacov, S.R.O.’s net profit margin increased by 13.62%.

Headquarters
Olomoucka 525
Tovacov; Olomoucky; Postal Code: 75101

Contact Details: Purchase the Renofarma Tovacov, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Renofarma Tovacov, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Renofarma Tovacov, S.R.O. report to view the information.
Registered Capital:
Purchase the Renofarma Tovacov, S.R.O. report to view the information.
Incorporation Date:
October 14, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Renofarma Tovacov, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
39.71%
Total operating revenue
34.9%
Operating profit (EBIT)
130.5%
EBITDA
108.68%
Net Profit (Loss) for the Period
135.28%
Total assets
24.3%
Total equity
67.99%
Operating Profit Margin (ROS)
16.5%
Net Profit Margin
13.62%
Return on Equity (ROE)
11.57%
Quick Ratio
0.98%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?